Assessment of Probability of Pulmonary Fibrosis Progression in Patients with Interstitial Lung Diseases to Determine Further Treatment Tactics-Reference-Cited by-同舟云学术

Assessment of Probability of Pulmonary Fibrosis Progression in Patients with Interstitial Lung Diseases to Determine Further Treatment Tactics

Published:2024-07-04 Issue:3 Volume:102 Page:34-40
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Lukashevich A. A.¹,Yudina O. A.²,Bogush L. S.³,Davidovskaya E. I.³,Dyusmikeeva M. I.³,Belko A. F.³

Affiliation:

1. Belarusian State Medical University

2. Republican Clinical Medical Center Administration of President of Belarus

3. Republican Scientific and Practical Center of Pulmonology and Phthisiology

Abstract

The objective: to develop a method for assessing the probability of progression of pulmonary fibrosis in patients with interstitial lung diseases in order to determine further treatment tactics.Subjects and Methods. 80 patients with interstitial lung diseases underwent lung biopsies with consequent morphological and immunohistochemical tests. The group with progressive fibrosis consisted of 42 patients. The prognostic model was built using the binary logistic regression method.Results. A statistical model was developed in the form of a regression equation consisting of 3 parameters: the presence of a morphological pattern of interstitial fibrosis; intensity of CTGF expression; and intensity of TGF-β expression. This mathematical model makes it possible to predict the progression of pulmonary fibrosis in patients with interstitial lung diseases with 83.3% sensitivity and 84.2% specificity.

Publisher

LLC "Medical Knowledge and Technologies"

Reference14 articles.

1. Glinskaya T.N. Incidence of respiratory diseases in the population above the working age in the Republic of Belarus. Voprosy Organizatsii I Informatizatsii Zdravookhraneniya, 2022, no. 3, pp. 18-31. (In Russ.)

2. Arnott J.A., Lambi A.G., Mundy C. et al. The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Critical Reviews in Eukaryotic Gene Expression, 2011, vol. 21, no. 1, pp. 43-69.

3. Behr J., Günther A., Bonella F. German guideline for idiopathic pulmonary fibrosis. Pneumologie, 2020, vol. 74, pp. 263-293.

4. Bradley B., Branley H.M., Egan J.J. et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax, 2008, vol. 63, suppl. 5, pp. 1-58.

5. Cottin V., Hirani N.A., Hotchkin D.L. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur. Respir. Rev., 2018, vol. 27, no. 150, pp. 180076. https://doi.org/10.1183/16000617.0076-2018